Alpha Tau Medical Analyst Ratings
Alpha Tau Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/17/2023 | 175.86% | Piper Sandler | $12 → $8 | Maintains | Overweight |
| 09/20/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 08/29/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 08/29/2023 | 693.1% | Cantor Fitzgerald | → $23 | Reiterates | Overweight → Overweight |
| 08/18/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/24/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/18/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 05/15/2023 | 210.34% | HC Wainwright & Co. | → $9 | Reiterates | Buy → Buy |
| 04/24/2023 | 210.34% | HC Wainwright & Co. | → $9 | Initiates Coverage On | → Buy |
| 11/23/2022 | 313.79% | Piper Sandler | $19 → $12 | Maintains | Overweight |
| 04/14/2022 | 589.66% | Cantor Fitzgerald | → $20 | Initiates Coverage On | → Overweight |
| 04/08/2022 | 555.17% | Piper Sandler | → $19 | Initiates Coverage On | → Overweight |
| 04/04/2022 | 624.14% | Citigroup | → $21 | Initiates Coverage On | → Buy |
| 日期 | 上行/下行 | 分析公司 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 11/17/2023 | 175.86% | 派珀·桑德勒 | 12 美元 → 8 美元 | 維護 | 超重 |
| 09/20/2023 | 210.34% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 08/29/2023 | 210.34% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 08/29/2023 | 693.1% | 坎託·菲茨傑拉德 | → 23 美元 | 重申 | 超重 → 超重 |
| 08/18/2023 | 210.34% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 05/24/2023 | 210.34% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 05/18/2023 | 210.34% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 05/15/2023 | 210.34% | HC Wainwright & Co. | → 9 美元 | 重申 | 購買 → 購買 |
| 04/24/2023 | 210.34% | HC Wainwright & Co. | → 9 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 2022 年 11 月 23 日 | 313.79% | 派珀·桑德勒 | 19 美元 → 12 美元 | 維護 | 超重 |
| 2022 年 4 月 14 日 | 589.66% | 坎託·菲茨傑拉德 | → 20 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 04/08/2022 | 555.17% | 派珀·桑德勒 | → 19 美元 | 啓動覆蓋範圍開啓 | → 超重 |
| 2022 年 4 月 4 日 | 624.14% | 花旗集團 | → 21 美元 | 啓動覆蓋範圍開啓 | → 購買 |
What is the target price for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的目標價格是多少？
The latest price target for Alpha Tau Medical (NASDAQ: DRTS) was reported by Piper Sandler on November 17, 2023. The analyst firm set a price target for $8.00 expecting DRTS to rise to within 12 months (a possible 175.86% upside). 10 analyst firms have reported ratings in the last year.
派珀·桑德勒於2023年11月17日公佈了Alpha Tau Medical（納斯達克股票代碼：DRTS）的最新目標股價。該分析公司將目標股價定爲8.00美元，預計DRTS將在12個月內升至12個月內（可能上漲175.86％）。去年有10家分析公司公佈了評級。
What is the most recent analyst rating for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的最新分析師評級是多少？
The latest analyst rating for Alpha Tau Medical (NASDAQ: DRTS) was provided by Piper Sandler, and Alpha Tau Medical maintained their overweight rating.
派珀·桑德勒對Alpha Tau Medical（納斯達克股票代碼：DRTS）的最新分析師評級由派珀·桑德勒提供，Alpha Tau Medical維持增持評級。
When is the next analyst rating going to be posted or updated for Alpha Tau Medical (DRTS)?
Alpha Tau Medical（DRTS）的下一份分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Alpha Tau Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Alpha Tau Medical was filed on November 17, 2023 so you should expect the next rating to be made available sometime around November 17, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Alpha Tau Medical的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月做一次這樣的評級，因此每家公司每年應該獲得4次評級。Alpha Tau Medical的最新評級是在2023年11月17日公佈的，因此您應該預計下一個評級將在2024年11月17日左右公佈。
Is the Analyst Rating Alpha Tau Medical (DRTS) correct?
分析師對Alpha Tau Medical（DRTS）的評級是否正確？
While ratings are subjective and will change, the latest Alpha Tau Medical (DRTS) rating was a maintained with a price target of $12.00 to $8.00. The current price Alpha Tau Medical (DRTS) is trading at is $2.90, which is out of the analyst's predicted range.
儘管評級是主觀的，並且會發生變化，但最新的Alpha Tau Medical（DRTS）評級保持不變，目標股價爲12.00美元至8.00美元。Alpha Tau Medical（DRTS）目前的交易價格爲2.90美元，超出了分析師的預期區間。
譯文內容由第三人軟體翻譯。